The increasing knowledge in molecular biology and the development of the techniques for the evaluation of the biological processes and of their interaction have brought about, in preclinical and clinical research, what is called precision medicine, to select the treatment that works best for an individual.
The development of new therapeutic approaches raises many ethical issues, of which investigators’ also and in particular at the preclinical level, should be aware of and take into consideration in their decisions and activities.
The objectives of this course are to increase this awareness of the ethical issues and of their potential impact in the selection and preclinical evaluation of new molecules, in the decision making process, in the care of patients and in the social environment.
In particular,
- in the planning and modalities of activation of clinical studies;
- in the selection of treatment, relationship and care of patients;
- in the collection of data and biological tissues;
- in the analysis, report, publication and sharing of data and results;
- in the active involvement of patients already at the beginning of the clinical project;
- in the registration, selling and marketing of therapeutic compounds in Europe.
This course it is offered also as parts of the PhD degree programme of the Faculty of Biomedical Sciences, USI and it is structured as common course (General skills).
Duration 1 day = 0.5 ECTS